First Light Asset Management »

Vaxcyte shares owned by First Light Asset Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.2M 142k 58.11
2025-03-31 $3.6M 94k 37.76
2024-06-30 $11M 140k 75.51
2024-03-31 $4.1M 60k 68.31

More positions owned by First Light Asset Management

Axogen Common Stocks (AXGN)
Palvella Therapeutics Common Stocks (PVLA)
Neogenomics Common Stocks (NEO)
Si-bone Common Stocks (SIBN)
Centessa Pharmaceuticals Common Stocks (CNTA)
Apogee Therapeutics Common Stocks (APGE)
Amylyx Pharmaceuticals Common Stocks (AMLX)
Twist Bioscience Corporation Common Stocks (TWST)
Crinetics Pharmaceuticals Common Stocks (CRNX)
908 Devices Common Stocks (MASS)
Neuropace Common Stocks (NPCE)
Edgewise Therapeutics Common Stocks (EWTX)
Anaptys Bio Common Stocks (ANAB)
Simulations Plus Common Stocks (SLP)
Guardant Health Common Stocks (GH)

View all positions for First Light Asset Management

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
T. Rowe Price Investment Management
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
State Street Corporation
Paradigm Biocapital Advisors
Deep Track Capital
Westfield Capital Management Company
Geode Capital Management
Kynam Capital Management

View all funds holding Vaxcyte